GLP-1 receptor agonists, are we witnessing the emergence of a paradigm shift for neuro-cardio-metabolic disorders?
<p dir="ltr">Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as groundbreaking therapeutic agents in managing a spectrum of <u>metabolic disorders</u>, demonstrating remarkable efficacy across multiple organ systems and disease states. These compounds ar...
Saved in:
| Main Author: | |
|---|---|
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|